CB

Curtis Bauer Lee

Active Director Director DIN 10728192
DIN 10728192 First appointment Aug 2024 Primary industry Information Technology
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2024
Shareholding value •••• Premium profile

About Curtis Bauer Lee

Data last updated:

Curtis Bauer Lee is a Director at Healthipass Private Limited (since 2024). The company operates in Information Technology. Healthipass Private Limited reported revenue of ₹4.23 Cr (FY 2025).

DIN 10728192
Primary Designation Director
Industry Information Technology
First Appointment 06 Aug 2024
Oldest Company Age 8 yrs
Largest company Healthipass Private Limited · ₹4.23 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Healthipass Private Limited U72501TG2018PTC123017
Director06 Aug 20242018₹4.23 Cr (FY 2025)Active

Board colleagues of Curtis Bauer Lee

Directorship timeline

Open interactive timeline →
Healthipass Private Limited
Premium access

Shareholding and investment profile for Curtis Bauer Lee

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Curtis Bauer Lee

Curtis Bauer Lee currently holds 1 directorship: Healthipass Private Limited (Director, since 06 Aug 2024, revenue ₹4.23 Cr (FY 2025)).

Curtis Bauer Lee was first appointed on 06 Aug 2024 as Director at Healthipass Private Limited.

The current boards of Curtis Bauer Lee's companies include Devi Venkata Siva Kalyan Babu Boppe (Healthipass Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available